Florida woman reaches remission with a positive attitude

Lucy Jamie, 88, of Hollywood Florida, was recently diagnosed in the advanced stages of non-Hodgkin's lymphoma (NHL) and has endured four months of chemotherapy.

Lucy is not unfamiliar with the effects of cancer. In 1991 she successfully battled lung cancer. Through all of her tribulations she has maintain a positive outlook. "I don't care much for what the year has brought me," she said. "I want [to] and will beat this cancer ... "



"Spending several hours in a lounge chair with intravenous injections of drugs into my arm was not painful! I have the positive attitude that the good cells were attacking the bad cells," she said.



Lucy said she tires easily and has had to curtail swimming 10 laps in her condo's pool every day, and playing Scrabble and Trivial Pursuit with her neighbors. But she has become a fan of television show Dancing With the Stars and thinks there should be a senior's version of the popular television show. She is thinking of taking dance lessons.



You can read more about Lucy's experiences in the Sun-Sentinal.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap